539 / 1031
CTV L2-L1: INDICATIONS
– No or inadequate lymphadenectomy (L)
RT L4-L3-L2-L1
– Bulky nodal disease
– SN (+) (Macrometastases) without lymphadenectomy
AMAROS Trial (EORTC)
(Adjuvant Management of the Axilla
R di th
f S g ) i
i g L ill
RT ith SN ( )
a o erapy o ur ery s compar n vs ax ary w + .
RT L4-L3-L2-L1
(Micrometastases: no RT)
AMAROS
Donker 2014 Lancet Oncol
Including 4800 patients demonstrated that axillary RT is as effective
as axillary surgery with less morbidity at 5 year follow-up.